Nanoviricides Inc
(NNVC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,555 | 4,237 | 3,904 | 6,082 | 7,082 |
| TOTAL | $2,825 | $4,630 | $4,073 | $6,284 | $7,322 |
| Non-Current Assets | |||||
| PPE Net | 10,227 | 10,390 | 10,556 | 10,707 | 10,841 |
| Intangibles | 367 | 369 | 371 | 373 | 375 |
| Other Non-Current Assets | 29 | 12 | 11 | 14 | 16 |
| TOTAL | $10,623 | $10,771 | $10,937 | $11,093 | $11,232 |
| Total Assets | $13,449 | $15,395 | $15,004 | $17,371 | $18,546 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,134 | 977 | 1,025 | 1,039 | 331 |
| Accrued Expenses | 69 | 108 | 139 | 231 | 253 |
| Other current liabilities | 1,646 | N/A | N/A | 123 | 298 |
| TOTAL | $2,848 | $1,084 | $1,164 | $1,392 | $882 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 1,593 | 0 | 0 | 0 |
| TOTAL | $N/A | $1,593 | $N/A | $N/A | $N/A |
| Total Liabilities | $2,848 | $2,677 | $1,164 | $1,392 | $882 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,845 | 3,837 | 3,475 | 3,469 | 3,469 |
| Common Shares | 4 | 77 | 70 | 69 | 69 |
| Retained earnings | -92,117 | -89,904 | -87,765 | -85,534 | -83,692 |
| Other shareholders' equity | 0 | 5 | 5 | 5 | 5 |
| TOTAL | $10,600 | $12,717 | $13,841 | $15,978 | $17,664 |
| Total Liabilities And Equity | $13,449 | $15,395 | $15,004 | $17,371 | $18,546 |